Comparable stake leader
Orin Hirschman
SEC ownership of RenovoRx, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001574094.
Disclosed value leader
Orin Hirschman
Comparable rows
33/47
Latest evidence
19 May 2026
- Public ticker
- RNXT on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Orin Hirschman
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
33 of 47
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Orin Hirschman
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
19 May 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001574094
- Issuer location
- Mountain View, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of RenovoRx, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Orin Hirschman
Disclosed value leader
Orin Hirschman
Comparable rows
33/47
Latest evidence
19 May 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.8%
14 rows are not safely comparable across share classes.
13D/G row: Orin Hirschman
Showing 1-8 of 47 holder rows.
Quick read
Orin Hirschman leads the comparable SEC ownership view at 9.8%.
33 of 47 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Orin Hirschman's linked filing trail.
Comparable ownership
Top 5
Orin Hirschman
9.8%
AWM Investment Company, Inc.
2.4%
AIGH Capital Management LLC
8.2%
Bleichroeder LP
3.7%
VANGUARD CAPITAL MANAGEMENT LLC
3.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 47 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Orin Hirschman |
13D/G
AIGH Capital Management LLC
|
9.8%
|
$4,474,798
4,430,493 shares
|
+$1,833,453 | 31 Mar 2026 |
| AWM Investment Company, Inc. |
13D/G
|
2.4%
|
$1,097,013
863,790 shares
|
-$1,278,172 | 30 Sep 2025 |
| AIGH Capital Management LLC |
13F
Company
|
8.2%
|
$3,681,777
3,706,197 shares
|
— | 31 Mar 2026 |
| Bleichroeder LP |
13F
Company
|
3.7%
|
$1,682,759
1,666,098 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
3.2%
|
$1,461,649
1,447,177 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.84%
|
$385,561
381,723 shares
|
— | 31 Mar 2026 |
| Wealthspire Advisors, LLC |
13F
Company
|
0.56%
|
$255,051
252,525 shares
|
— | 31 Mar 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.51%
|
$235,011
232,684 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$93,723.
Buys
$93,723
Insiders: 3
Sells
$0
Insiders: 0
Net
+$93,723
Shares: +109,000
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 109,000
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 25,000 | 0 | $19,690 | $0 | +$19,690 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 74,000 | 0 | $64,737 | $0 | +$64,737 |
| 9-12 | 10,000 | 0 | $9,296 | $0 | +$9,296 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-16 of 16 reporting-owner rows connected to RenovoRx, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
16
Largest Forms 3/4/5 holder
Kamran Najmabadi
Net 12M change
+$93,723
Latest report
19 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Kamran Najmabadi | 10%+ Owner | $1,029,324 | Mixed | 25 Aug 2021 | ||
| BANK OF THE WEST | 10%+ Owner | $1,018,875 | Mixed | 16 Mar 2022 | ||
| Ramtin Agah | Chief Medical Officer, Director | $796,463 | +$55,968 | +7.6% | Filing P/S | 03 Apr 2026 |
| Shaun Bagai | Chief Executive Officer, Director | $306,081 | +$18,065 | +6.3% | Mixed | 03 Apr 2026 |
| Mark Voll | Chief Financial Officer | $210,310 | +$19,690 | +10% | Mixed | 19 May 2026 |
| Una S. Ryan | Director | $89,391 | Mixed | 01 Oct 2025 | ||
| Paul Manners | Chief Financial Officer | $24,383 | Mixed | 25 Aug 2021 | ||
| Laurence Marton | Director | $18,089 | Mixed | 20 Mar 2026 | ||
| Ron Kocak | VP, Controller and PAO | $9,950 | Filing P/S | 01 Jul 2025 | ||
| Angela Gill Nelms | Chief Operating Officer | $1,150 | Filing P/S | 19 Jan 2024 | ||
| Robert J. Spiegel | Director | Mixed | 01 Oct 2025 | |||
| James M. Ahlers | Chief Financial Officer | Mixed | 15 Jul 2022 | |||
| Christopher J. Lehman | Chief Financial Officer | Mixed | 30 Aug 2021 | |||
| K. Angela Macfarlane | Director | Mixed | 01 Oct 2025 | |||
| David Diamond | Director | Mixed | 01 Oct 2023 | |||
| Leesa Gentry | Chief Clinical Officer | Mixed | 03 Apr 2026 |
Recent insider transactions for RenovoRx, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Mark Voll | RNXT | Common Stock | Purchase | 21.3% | $19,690 | $0.7876 | 25,000 | 142,380 | 19 May 2026 | Direct |
| Shaun Bagai | RNXT | Stock Option | Award | 946,107 | 946,107 | 03 Apr 2026 | Direct | |||
| Mark Voll | RNXT | Common Stock | Award | 214% | 80,000 | 117,380 | 03 Apr 2026 | Direct | ||
| Leesa Gentry | RNXT | Stock Option | Award | 128,550 | 128,550 | 03 Apr 2026 | Direct | |||
| Ramtin Agah | RNXT | Stock Option | Award | 621,727 | 621,727 | 03 Apr 2026 | Direct | |||
| Mark Voll | RNXT | Common Stock | Award | 49.5% | 12,380 | 37,380 | 25 Mar 2026 | Direct | ||
| Laurence Marton | RNXT | Common Stock | Purchase | 9,720 | 9,720 | 20 Mar 2026 | Laurence Marton Rollover IRA | |||
| Laurence Marton | RNXT | Warrants | Purchase | 4,860 | 4,860 | 20 Mar 2026 | Laurence Marton Rollover IRA | |||
| Shaun Bagai | RNXT | Common Stock | Purchase | 8.41% | 24,300 | 313,357 | 20 Mar 2026 | The Bagai Family Trust | ||
| Shaun Bagai | RNXT | Warrants | Purchase | 12,150 | 12,150 | 20 Mar 2026 | The Bagai Family Trust | |||
| Mark Voll | RNXT | Common Stock | Purchase | 97,200 | 97,200 | 20 Mar 2026 | Voll Family Trust DTD 6/23/2010 Mark Voll TTEE | |||
| Mark Voll | RNXT | Warrants | Purchase | 48,600 | 48,600 | 20 Mar 2026 | Voll Family Trust DTD 6/23/2010 Mark Voll TTEE | |||
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.27% | $9,975 | $0.9975 | 10,000 | 798,460 | 21 Jan 2026 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.26% | $8,424 | $0.8600 | 9,795 | 788,460 | 31 Dec 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 0.03% | $169 | $0.8260 | 205 | 778,665 | 30 Dec 2025 | Direct |
| Shaun Bagai | RNXT | Common Stock | Purchase | 1.49% | $4,506 | $0.9013 | 5,000 | 340,040 | 18 Dec 2025 | Direct |
| Shaun Bagai | RNXT | Common Stock | Purchase | 1.51% | $4,262 | $0.8524 | 5,000 | 335,040 | 17 Dec 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.57% | $10,200 | $0.8500 | 12,000 | 778,460 | 16 Dec 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.32% | $9,600 | $0.9600 | 10,000 | 766,460 | 05 Dec 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.61% | $9,600 | $0.8000 | 12,000 | 756,460 | 24 Nov 2025 | Direct |
| Ramtin Agah | RNXT | Common Stock | Purchase | 1.36% | $8,000 | $0.8000 | 10,000 | 744,460 | 21 Nov 2025 | Direct |
| Laurence J. Marton | RNXT | Stock Options (right to buy) | Award | 47,640 | 47,640 | 01 Oct 2025 | Direct | |||
| K. Angela Macfarlane | RNXT | Stock Options (right to buy) | Award | 47,640 | 47,640 | 01 Oct 2025 | Direct | |||
| Una S. Ryan | RNXT | Stock Options (right to buy) | Award | 47,640 | 47,640 | 01 Oct 2025 | Direct | |||
| Robert J. Spiegel | RNXT | Stock Options (right to buy) | Award | 47,640 | 47,640 | 01 Oct 2025 | Direct | |||
| Shaun Bagai | RNXT | Common Stock | Purchase | 1.54% | $4,549 | $0.9098 | 5,000 | 330,040 | 25 Aug 2025 | Direct |
| Shaun Bagai | RNXT | Common Stock | Purchase | 1.56% | $4,748 | $0.9495 | 5,000 | 325,040 | 22 Aug 2025 | Direct |
* marks a reported price that did not pass the local price check.